Quarterly report (Form 10-Q)
West Pharmaceutical Services 10-Q for Quarter ended Sep 30, 2026
Filing excerpt
The net benefit is composed of a net gain on the sale of its SmartDose® 3.5mL On-Body Delivery System assets of $55.7 million for the three and nine months ended September 30, 2026 within other expense (income).